Life In The Fast Lane At Nova Pharmaceuticals, And The Not-So-Sweet Smell Of Success

To hear pharmacologist Bill Kinnier tell it, life at Nova Pharmaceutical Corp. has finally settled down. He’s back to being a full-time scientist He gets to go home at a normal hour. He even has a new secretary all to himself. The only problem is: Kinnier misses the old days.

Take the summer of 1984. Nova, a hot pharmaceutical startup, had been born of a dream that renowned Johns Hopkins University neuroscientist Solomon Snyder could spin off powerful and profitable drugs from his pioneering work on nervous system receptors.

Barely a year old, the firm was still in its vagabond stage, promising enough to have outgrown its home for the second time in a few months. This time the man in charge, the director of research, was preparing to consolidate two labs into one much larger...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?